Journal of Clinical Medicine (Aug 2020)

Mobile-Based Lifestyle Intervention in Women with Glucose Intolerance after Gestational Diabetes Mellitus (MELINDA), A Multicenter Randomized Controlled Trial: Methodology and Design

  • Caro Minschart,
  • Toon Maes,
  • Christophe De Block,
  • Inge Van Pottelbergh,
  • Nele Myngheer,
  • Pascale Abrams,
  • Wouter Vinck,
  • Liesbeth Leuridan,
  • Chantal Mathieu,
  • Jaak Billen,
  • Christophe Matthys,
  • Babs Weyn,
  • Annouschka Laenen,
  • Annick Bogaerts,
  • Katrien Benhalima

DOI
https://doi.org/10.3390/jcm9082635
Journal volume & issue
Vol. 9, no. 8
p. 2635

Abstract

Read online

The aims of the ‘Mobile-based lifestyle intervention in women with glucose intolerance after gestational diabetes mellitus (GDM)’ study (MELINDA) are: (1) to evaluate the prevalence and risk factors of glucose intolerance after a recent history of GDM; and (2) to evaluate the efficacy and feasibility of a telephone- and mobile-based lifestyle intervention in women with glucose intolerance after GDM. This is a Belgian multicenter randomized controlled trial (RCT) in seven hospitals with the aim of recruiting 236 women. Women in the intervention group will receive a blended program, based on one face-to-face education session and further follow-up through a mobile application and monthly telephone advice. Women in the control group will receive follow-up as in normal routine with referral to primary care. Participants will receive an oral glucose tolerance test (OGTT) one year after baseline. Primary endpoint is the frequency of weight goal achievement (≥5% weight loss if pre-pregnancy BMI ≥ 25 Kg/m2 or return to pre-gravid weight if BMI 2). At each visit blood samples are collected, anthropometric measurements are obtained, and self-administered questionnaires are completed. Recruitment began in May 2019.

Keywords